期刊文献+

四氯化碳不同注射方式诱导大鼠不同分期肝纤维化模型的研究 被引量:11

Study on Different Stages of Hepatic Fibrosis Induced by Different Injection of Carbon Tetrachloride in Rats
下载PDF
导出
摘要 目的研究四氯化碳不同注射方式对构建大鼠不同分期肝纤维化模型的作用,为四氯化碳诱导大鼠不同分期肝纤维化模型提供可靠的方法。方法 42只雄性SD大鼠随机分成皮下及腹腔注射组,每周2次分别于后腿内侧皮下、腹腔注射四氯化碳-食用调和油悬浊液。第6周开始各组分别处死2~3只大鼠进行肝纤维化分期。结果皮下注射组造模期间死亡3只,死亡率14.3%;腹腔注射组造模期间死亡11只,死亡率52.4%,两种注射方式死亡率明显差异(P<0.05)。皮下注射组第7周获得有意义肝纤维化,第12周造模完成,造模完成时获得有意义肝纤维大鼠11只;腹腔注射组第6周获得有意义肝纤维化,第10周造模完成,造模完成时获得有意义肝纤维大鼠10只,两种注射方式获得有意义肝纤维化无统计学意义(P>0.05)。结论腹腔及皮下注射方式均可建立大鼠不同分期肝纤维化模型;皮下注射造模死亡率较腹腔注射低,造模完成时间较长,两种注射方式获得有意义肝纤维无明显差异。 Objective To study the effect of different injection methods of carbon tetrachloride on the establishment of different stages of hepatic fibrosis models in rats,and to provide a reliable method for carbon tetrachloride induced different stages of hepatic fibrosis models in rats.Methods 42 male SD rats were randomly divided into subcutaneous and intraperitoneal injection group,carbon tetrachloride-edible blend oil suspension was injected 2 times a week in hind leg medial skin and abdominal cavity.From the sixth week,2-3 rats were executed in each group for hepatic fibrosis staging.Results During the modeling period,3 rats died in the subcutaneous injection group,the mortality rate was 14. 3%; 11 cases died in the intraperitoneal injection group,the mortality rate was 52. 4%,and the mortality of the two injection methods was obviously different( P〈0. 05).Subcutaneous injection group used seven weeks to get significant liver fibrosis,twelve weeks to finish modeling,and obtained 11 rats with significant hepatic fibrosis.Intraperitoneal injection group used six weeks to get significant liver fibrosis,ten weeks to finish modeling,and obtained10 rats with significant hepatic fibrosis.There was no significant difference between the two injection methods obtaining significant hepatic fibrosis( P〈0. 05). Conclusion The liver fibrosis models of rats can be established by intraperitoneal and subcutaneous injection methods; the mortality of subcutaneous injection molding was lower than that of intraperitoneal injection,and the model completion time was longer.There was no significant difference between two injection methods in obtaining significant hepatic fibrosis.
作者 金明丽 潘志华 舒健 卢欣 王晓凤 柴丽 Jin Mingli;Pan Zhihua;Shu Jian;et al(416 Hospital of Nuclear Industry&Department of Radiology, the Second Affiliated Hospital of Chengdu Medical College, Chengdu , Sichuan 610000;The First Affiliated Hospital of Southwest Medical University, Luzhou , Si- chuan 646000, China)
出处 《四川医学》 CAS 2018年第3期270-272,共3页 Sichuan Medical Journal
基金 四川省卫生和计划生育委员会科研课题(编号:17PJ436)
关键词 四氯化碳 肝纤维化模型 大鼠 carbon tetrachloride hepatic fibrosis model rats
  • 相关文献

参考文献4

二级参考文献24

  • 1李隽,曹治宸.NO在CCl_4致大鼠肝纤维化中的氧化应激作用[J].解放军医学杂志,2006,31(3):234-236. 被引量:19
  • 2何雅军,舒建昌,吕霞,方力,沈雁.姜黄素预防肝纤维化作用与肝星状细胞的关系[J].中华肝脏病杂志,2006,14(5):337-340. 被引量:37
  • 3马玉珍,韩景田,陈玮,叶路.四氯化碳皮下注射制备肝纤维化模型的新设计[J].四川动物,2007,26(3):697-698. 被引量:10
  • 4JIAO J,FRIEDMAN S L,ALOMAN C.Hepatic fibrosis[J].Curr Opin Gastroenterol,2009,25(3):223-229.
  • 5SHU J C,HE Y J,LV X,et al.Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells[J].J Nat Med,2009,63:415-420.
  • 6SHU J C,H E Y J,LV X,et al.Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells[J].Braz J Med Biol Res,2009,42(12):1173-1178.
  • 7FAILLI P,DEFRANCO R M,CALIGIURI A,et al.Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells[J].Gastroenterology,2000,119:479-492.
  • 8LIU Y,WEN X M,LUI E L,et al.Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258[J].Lab Invest,2009,89(10):1152-1160.
  • 9GRESSNER A M,WEISKIRCHEN R,BREITKOPF K,et al.Roles of TGF-beta in hepatic fibrosis[J].Front Biosci,2002,7:793-807.
  • 10PINZANI M,GENTILINI A,CALIGIURI A,et al.Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells[J].Hepatology,1995,21(1):232-239.

共引文献413

同被引文献134

引证文献11

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部